A detailed history of Bogart Wealth, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Bogart Wealth, LLC holds 1,450 shares of DNA stock, worth $507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,450
Previous 750 93.33%
Holding current value
$507
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$1.06 - $1.67 $742 - $1,169
700 Added 93.33%
1,450 $1,000
Q4 2023

Feb 06, 2024

BUY
$1.26 - $1.79 $945 - $1,342
750 New
750 $1,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $451M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Bogart Wealth, LLC Portfolio

Follow Bogart Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.